Exclusive interviews with leading policymakers that convey the true policy message that impacts markets.
Reporting on key macro data at the time of release.
Real-time insight on key fixed income and fx markets.
- Emerging MarketsEmerging Markets
Real-time insight of emerging markets in CEMEA, Asia and LatAm region
- Political RiskPolitical Risk
Intelligence on key political and geopolitical events around the world.
- About Us
Sign up now for free access to this content.
Please enter your details below and select your areas of interest.
- Markets read concern into Johnson & Johnson's decision to delay and stall the rollout of their COVID-19 vaccine across Europe, with the US CDC also deciding to pause the jab's use domestically over blood-clotting concerns.
- In response, the three main US indices slipped sharply alongside J&J shares, which fell as much as 3% and dragged on the Dow Jones Industrial Average, which traded lower against minor gains for the S&P 500 and NASDAQ. Utilities, consumer discretionary and tech outperformed, while financials and industrials lagged.
- The e-mini S&P wholly erased the initial vaccine-induced dip, which was preceded by a new all time high, keeping the recent run of strength very much in tact. The index trades with month-to-date gains of close to 4%.
- Earnings season kicks off materially Wednesday, with JPMorgan, Goldman Sachs and Wells Fargo all reporting.